MTOR and cyst: Many mTOR inhibitors were selected as hits, but to our surprise, PI3K inhibitors were not, even though this has been described as a pathway involved in cyst growth.23,24 We therefore tested a larger panel of inhibitors for both protein targets and found that indeed, while mTOR inhibitors showed potent efficacy, PI3K inhibitors generally lacked inhibitory activity.